SEC 13F Intelligence

Propel Bio Management, LLC / PHAT

Propel Bio Management, LLC’s Phathom Pharmaceuticals Inc Position

Does Propel Bio Management, LLC own Phathom Pharmaceuticals Inc (PHAT)? Yes — 841.3K shares worth $9M (+5.90% of its 13F portfolio) as of Q1 2026, up from 740.9K shares the prior filed quarter.

Position Value
$9M
Q1 2026
Shares
841.3K
% of Portfolio
+5.90%
Quarters Held
10
currently held

Position History PHAT

Reported value by quarter
Q4 ’23: $4MQ4 ’23Q1 ’24: $9MQ2 ’24: $9MQ2 ’24Q3 ’24: $16MQ4 ’24: $8MQ4 ’24Q1 ’25: $7MQ2 ’25: $9MQ2 ’25Q3 ’25: $7MQ4 ’25: $12MQ4 ’25Q1 ’26: $9Mfilingsflow.com
QuarterSharesValue% of Portfolio
Q1 2026841.3K$9M+5.90%
Q4 2025740.9K$12M+10.49%
Q3 2025552.9K$7M+6.51%
Q2 2025922.9K$9M+10.74%
Q1 20251.13M$7M+8.27%
Q4 2024989.9K$8M+7.98%
Q3 2024869.9K$16M+9.12%
Q2 2024869.9K$9M+5.81%
Q1 2024869.9K$9M+5.38%
Q4 2023443.0K$4M+3.35%

Common-stock position only; options are excluded. Quarters where the fund filed no 13F or reported no position are absent. See Propel Bio Management, LLC’s full portfolio or all institutional holders of PHAT.